Iovance Biotherapeutics, Inc.
Iovance Biotherapeutics, Inc. (IOVA) — Form SCHEDULE 13G: Ownership over 5% (passive)
About this filing
Iovance Biotherapeutics, Inc. (IOVA) filed Form SCHEDULE 13G (ownership over 5% (passive)) with the SEC on Nov 10, 2026. A Schedule 13G reports a passive investor owning more than 5% of the company.
Key facts
- Document
- —
More IOVA filings
- 4
Filed Nov 10, 2026
- 8-K
Filed Nov 5, 2026
- 10-Q
Filed Nov 5, 2026
- 8-K
Filed Nov 5, 2026
- 8-K
Filed Oct 29, 2026
- 8-K
Filed Oct 5, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.